Latest Comments

COPD severity differs by severity system used

COPD severity differs by severity system used

NeuPSIG 2017: personalized treatments may hold the key to treatment progress in neuropathic pain

NeuPSIG 2017: personalized treatments may hold the key to treatment progress in neuropathic pain

NeuPSIG 2017: cell therapies may hold the key to opioid use in neuropathic pain

NeuPSIG 2017: cell therapies may hold the key to opioid use in neuropathic pain

EULAR 2017: Big pharma dives back into the lupus pipeline

EULAR 2017: Big pharma dives back into the lupus pipeline

DEVOTE trial update: ultra long-acting Insulin Tresiba as safe as insulin glargine

DEVOTE trial update: ultra long-acting Insulin Tresiba as safe as insulin glargine

GSK’s tafenoquine could spell the end for relapsing P. vivax malaria

GSK’s tafenoquine could spell the end for relapsing P. vivax malaria

EULAR 2017: Mixed Expectations on Use of Biosimilars in Rheumatoid Arthritis

EULAR 2017: Mixed Expectations on Use of Biosimilars in Rheumatoid Arthritis

U-turn: life-prolonging breast cancer drug now available on the NHS

U-turn: life-prolonging breast cancer drug now available on the NHS

Understanding the risk of over treatment in Type 2 Diabetes

Understanding the risk of over treatment in Type 2 Diabetes

EULAR 2017: progress made as scientist seek to unify Lupus field

EULAR 2017: progress made as scientist seek to unify Lupus field

Loss of exclusivity to limit J&J gain after Zytiga label extension

Loss of exclusivity to limit J&J gain after Zytiga label extension

Chemo-free triplet regimens on the horizon for CLL

Chemo-free triplet regimens on the horizon for CLL

Practice changing results at the ASCO conference: Lynparza is poised to modify the treatment paradigm of metastatic breast cancer

Practice changing results at the ASCO conference: Lynparza is poised to modify the treatment paradigm of metastatic breast cancer

Poor tolerability of Opdivo + Yervoy in frontline NSCLC could be Achilles heel

Poor tolerability of Opdivo + Yervoy in frontline NSCLC could be Achilles heel

Increased risk of amputation if taking type 2 diabetes drug Invokana

Increased risk of amputation if taking type 2 diabetes drug Invokana

Roundup of Key Oncology Strategic Alliances in Q1 2017

Roundup of Key Oncology Strategic Alliances in Q1 2017

New drug class set to reduce migraine misery

New drug class set to reduce migraine misery

Highlights from the 2017 ATS Conference

Highlights from the 2017 ATS Conference

HIV and malaria: case studies in combatting drug resistance through improved adherence

HIV and malaria: case studies in combatting drug resistance through improved adherence

How your gut microbiome can interfere with cancer treatment and how to avoid it

How your gut microbiome can interfere with cancer treatment and how to avoid it

Eiger Bio’s PAH drug Ubenimex moves one step closer to fulfilling an unmet need

Eiger Bio’s PAH drug Ubenimex moves one step closer to fulfilling an unmet need